Cardiac biomarkers are one of those Step “make-or-break” topics: you’ll see chest pain, an EKG that’s “not definitive,” and you’ll need to decide what’s happening and when it happened. Troponin and CK-MB are the core players—learn their timelines, what they actually measure, and the classic traps (renal failure, myocarditis, reinfarction), and you’ll pick up easy points on both Step 1 and Step 2.
Where biomarkers fit in coronary & ischemic heart disease
In acute coronary syndrome (ACS), plaque rupture → thrombus → reduced coronary blood flow → ischemia (reversible) and potentially infarction (irreversible myocyte necrosis).
Biomarkers rise when myocardial cell membranes lose integrity, releasing intracellular proteins into the blood. This is why biomarkers diagnose MI/infarction, not just ischemia.
Key distinction (high-yield)
- Angina (stable/unstable) = ischemia without necrosis → biomarkers typically negative
- MI (NSTEMI/STEMI) = necrosis → biomarkers positive (especially troponin)
First Aid cross-reference: Cardiovascular → Ischemic heart disease / MI, the “markers over time” figure/table is a classic.
Pathophysiology: why troponin and CK-MB rise
Troponin (TnI and TnT)
Troponin is part of the contractile regulatory complex in striated muscle:
- TnC binds calcium (not cardiac-specific)
- TnI inhibits actin-myosin interaction (cardiac-specific isoform)
- TnT binds tropomyosin (cardiac isoform used clinically)
Injury mechanism: myocyte necrosis → cytosolic troponin release (early) + structural troponin release (sustained elevation).
CK-MB
Creatine kinase (CK) exists as isoenzymes:
- CK-MM (skeletal muscle)
- CK-BB (brain)
- CK-MB (relatively more cardiac; also present in skeletal muscle)
Injury mechanism: myocyte necrosis releases CK-MB. Because it clears faster than troponin, it’s useful for detecting reinfarction.
First Aid cross-reference: Biochemistry → muscle enzymes (CK) and Cardio → MI biomarkers timeline.
The Step-friendly timeline table (must memorize)
| Biomarker | Rises after MI | Peaks | Returns to normal | Classic use |
|---|---|---|---|---|
| Troponin I/T | 3–4 hours (can be 2–3h with high-sensitivity assays) | 24–48 hours | 7–10 days (sometimes up to ~14) | Most sensitive & specific for MI |
| CK-MB | 4–6 hours | 18–24 hours | 2–3 days | Reinfarction (new rise after it normalized) |
| (Historical) Myoglobin | 1–2 hours | 6–9 hours | <24 hours | Early but nonspecific (rarely tested now) |
High-yield pearl: Troponin stays elevated so long that it can “mask” a second MI occurring a few days later → CK-MB helps because it returns to baseline sooner.
Clinical presentation: when to suspect you need biomarkers
Typical ACS symptoms
- Substernal pressure (not sharp), may radiate to left arm/jaw
- Diaphoresis, nausea/vomiting
- Dyspnea
- Symptoms often last >20 minutes and can occur at rest (unstable angina/MI)
Atypical presentations (Step 2 favorite)
- Diabetics, elderly, women: more likely dyspnea, fatigue, nausea, epigastric discomfort
- “Silent MI” can happen—still get biomarkers if suspicion is high.
Diagnosis: how biomarkers are actually used (real-world + USMLE)
MI requires more than a positive troponin
Per modern definitions, MI is diagnosed with:
- Rise/fall of troponin with at least one value above the 99th percentile, plus evidence of ischemia, such as:
- ischemic symptoms
- new ischemic EKG changes
- imaging evidence of new loss of viable myocardium
- identification of coronary thrombus
Translation for exams: a single mildly elevated troponin isn’t automatically MI—context matters.
Serial troponins are key
If initial troponin is negative but suspicion remains:
- Repeat at 3–6 hours (institution-dependent; often 0 and 3 hours with high-sensitivity troponin).
STEMI vs NSTEMI vs unstable angina (what biomarkers do)
- STEMI: ST elevations (or new LBBB equivalent patterns) + positive troponin
- NSTEMI: no ST elevation but positive troponin
- Unstable angina: no ST elevation and troponin negative (or not above diagnostic threshold)
First Aid cross-reference: ST elevation MI vs NSTEMI vs unstable angina chart; treatment algorithms section.
Troponin: the nuance USMLE likes
When troponin is elevated without MI (common traps)
Troponin indicates myocardial injury, not necessarily a type 1 plaque-rupture MI.
High-yield causes:
- Myocarditis (often post-viral; chest pain, maybe diffuse ST elevation; can mimic MI)
- Heart failure exacerbation
- Tachyarrhythmias (demand ischemia)
- Pulmonary embolism (RV strain can bump troponin)
- Sepsis/critical illness
- Renal failure (CKD/ESRD): especially troponin T can be chronically elevated
- Cardiac contusion (trauma)
- Takotsubo cardiomyopathy (stress-induced)
Step move: If you see elevated troponin + normal coronaries or clear alternative cause, think “injury” rather than classic MI.
Type 1 vs Type 2 MI (Step 2 framing)
- Type 1 MI: plaque rupture + thrombus (classic ACS)
- Type 2 MI: supply-demand mismatch (anemia, tachycardia, hypotension); can raise troponin
CK-MB: why it still matters
Reinfarction
If a patient had an MI and then has new chest pain 2 days later:
- Troponin may still be elevated from the first event.
- A second rise in CK-MB after it had begun to fall (or after normalization) supports reinfarction.
False positives / limitations
Because CK-MB exists in skeletal muscle too:
- Skeletal muscle injury (trauma, rhabdomyolysis) can elevate CK-MB
- Less specific than troponin overall
Treatment: what you do while biomarkers are pending
On exams, you treat suspected ACS based on clinical suspicion and EKG, not waiting for labs.
Immediate ACS management (high-yield scaffold)
Common Step mnemonic: MONA-B (not perfect, but helps structure)
- Morphine: for pain refractory to nitrates (use carefully; can mask symptoms)
- Oxygen: only if hypoxemic (modern practice; Step often still mentions O2)
- Nitrates: relieve ischemic pain (contraindicated with hypotension, RV infarct, PDE-5 inhibitors)
- Aspirin: reduces mortality (antiplatelet)
- Beta-blocker: decreases myocardial oxygen demand (avoid in acute decomp HF, bradycardia, shock)
Add:
- P2Y12 inhibitor (clopidogrel/ticagrelor) for ACS
- Anticoagulation (heparin) for NSTEMI/unstable angina; also used in many STEMI protocols pre-PCI
- High-intensity statin
- Reperfusion for STEMI: PCI preferred; thrombolysis if PCI unavailable within recommended time window and no contraindications
First Aid cross-reference: Pharm: antianginals, antiplatelets, anticoagulants; Cardio: MI management and complications.
High-yield associations & classic question stems
1) “Chest pain + normal EKG + early presentation”
- Troponin may be negative if very early.
- Repeat serial troponins; manage clinically if suspicion high.
2) “Troponin elevated + diffuse ST elevations”
- Think myocarditis or pericarditis (pericarditis classically has diffuse ST elevation + PR depression; troponin can be mildly elevated if myopericarditis).
3) “Kidney disease + chronically elevated troponin”
- Don’t anchor on a single value; look for dynamic change (rise/fall) and ischemic context.
4) “Second MI a few days later”
- Troponin still high from the first MI → use CK-MB (or look for a significant delta troponin depending on the question).
5) “Timing questions”
If they ask when it peaks/returns to normal:
- Troponin: peaks ~1–2 days, normal in 7–10 days
- CK-MB: normal in 2–3 days
Quick comparison: troponin vs CK-MB (Step 1-friendly)
| Feature | Troponin | CK-MB |
|---|---|---|
| Specificity for cardiac muscle | High (esp TnI) | Moderate |
| Sensitivity for MI | Highest | Lower than troponin |
| Duration of elevation | Long (days) | Short (2–3 days) |
| Best for reinfarction | Not ideal (stays high) | Yes |
| Common non-MI elevations | CKD, sepsis, PE, myocarditis, HF | Skeletal muscle injury, surgery/trauma |
Rapid-fire Step takeaways (memorize these)
- Troponin is the best overall biomarker for MI (sensitive + specific).
- CK-MB is best for reinfarction because it returns to baseline in 48–72 hours.
- Biomarkers diagnose necrosis, not mere ischemia—unstable angina usually has negative troponin.
- Elevated troponin ≠ always plaque rupture MI; think myocardial injury causes (CKD, myocarditis, PE, sepsis).
- If presentation is early and troponin is negative, repeat—don’t prematurely rule out MI.